1. Home
  2. OPK vs CINT Comparison

OPK vs CINT Comparison

Compare OPK & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • CINT
  • Stock Information
  • Founded
  • OPK 2007
  • CINT 1995
  • Country
  • OPK United States
  • CINT Brazil
  • Employees
  • OPK N/A
  • CINT N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • CINT EDP Services
  • Sector
  • OPK Health Care
  • CINT Technology
  • Exchange
  • OPK Nasdaq
  • CINT Nasdaq
  • Market Cap
  • OPK 1.1B
  • CINT 803.4M
  • IPO Year
  • OPK 1995
  • CINT 2021
  • Fundamental
  • Price
  • OPK $1.34
  • CINT $5.55
  • Analyst Decision
  • OPK Buy
  • CINT Buy
  • Analyst Count
  • OPK 4
  • CINT 7
  • Target Price
  • OPK $2.75
  • CINT $7.61
  • AVG Volume (30 Days)
  • OPK 3.3M
  • CINT 91.6K
  • Earning Date
  • OPK 08-06-2025
  • CINT 08-15-2025
  • Dividend Yield
  • OPK N/A
  • CINT N/A
  • EPS Growth
  • OPK N/A
  • CINT 53.80
  • EPS
  • OPK N/A
  • CINT 0.24
  • Revenue
  • OPK $689,408,000.00
  • CINT $444,135,000.00
  • Revenue This Year
  • OPK N/A
  • CINT $526.02
  • Revenue Next Year
  • OPK $6.98
  • CINT $12.77
  • P/E Ratio
  • OPK N/A
  • CINT $23.10
  • Revenue Growth
  • OPK N/A
  • CINT 3.04
  • 52 Week Low
  • OPK $1.21
  • CINT $4.42
  • 52 Week High
  • OPK $2.04
  • CINT $8.04
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.42
  • CINT 39.58
  • Support Level
  • OPK $1.32
  • CINT $5.89
  • Resistance Level
  • OPK $1.36
  • CINT $5.94
  • Average True Range (ATR)
  • OPK 0.04
  • CINT 0.17
  • MACD
  • OPK 0.00
  • CINT -0.03
  • Stochastic Oscillator
  • OPK 65.38
  • CINT 3.51

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About CINT CI&T Inc

CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

Share on Social Networks: